Guangdong, China

Ju Peng


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):

Title: The Innovative Journey of Inventor Ju Peng

Introduction

Ju Peng is an accomplished inventor based in Guangdong, China. With a keen focus on pharmaceutical innovations, he has made significant contributions through his research and patented inventions. His work primarily revolves around novel compounds that play a crucial role in treating protein kinase-mediated diseases.

Latest Patents

One of Ju Peng's most notable patents includes a groundbreaking invention related to substituted heteroaryl compounds. This patent covers novel heteroaryl compounds, their pharmaceutical acceptable salts, and formulations. The innovative compounds are designed to prevent, manage, and treat diseases mediated by protein kinases, thereby offering a promising avenue for therapeutic advancements. Additionally, the invention encompasses pharmaceutically acceptable compositions and methods of using these compounds effectively in treatment protocols.

Career Highlights

Throughout his career, Ju Peng has worked with several esteemed organizations, notably Calitor Sciences, LLC, and North & South Brother Pharmacy Investment Company Limited. His experience in these companies has further honed his expertise in pharmaceutical development and innovation, significantly contributing to his patent achievements.

Collaborations

Ju Peng has cultivated collaborations with talented individuals in the field. Notable coworkers include Ning Xi and Minxiong Li, both of whom have played a role in his professional journey and contributed to the innovative atmosphere within their respective projects.

Conclusion

Ju Peng's contributions to the field of pharmaceuticals through his innovative patents and collaborations reflect his dedication to tackling complex medical challenges. As an inventor, he continues to inspire others in the realm of scientific discovery and innovation, paving the way for future advancements in the treatment of protein kinase-mediated diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…